Bluebird bio
Price & Volume
Stats
See more52W Range | $5.80-$38.40 |
Market Cap | $82.6M |
Shares Short | 49M |
Financials
See moreRevenue (12 Mos) | $54.9M |
Revenue Growth (YoY) | 133.7% |
Gross Profit (12 Mos) | -$247.2M |
Diluted EPS | -$36 |
News
See moreYahoo Finance • last year
12 Most Promising Gene Editing Stocks According to Hedge Funds
Yahoo Finance • last year
Down 30% in a Week, What in the World Is Going On With Bluebird Bio Stock?
Yahoo Finance • last year
bluebird bio Details Plans for the Commercial Launch of LYFGENIA™ Gene Therapy for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events
Yahoo Finance • last year
Bluebird Bio Inc (BLUE) Reports Q3 2023 Financial Results: Strong Commercial Launch and ...
About
CEO | Mr. Andrew Obenshain |
CFO | Mr. Oliver James Sterling III |
Address | 455 Grand Union Boulevard, Somerville, MA, United States, 02145 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 375 |
